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Abstract
Background: The incidence of biliary complications following liver transplantation (LT) remains high, ranging from
10 to 50 % of patients, especially when the diameter of the bile duct is smaller than 7 mm. Biliary reconstruction is
most often performed by duct-to-duct anastomosis. In a preliminary study (n = 20), we previously reported a
technique of biliary reconstruction using an intraductal stent tube followed by its endoscopic removal and showed
both the feasibility and safety of this innovative procedure. The next step is to validate the potential benefit of this
procedure in a randomized controlled trial.
Design: This is a multicenter randomized controlled trial in France comparing the efficacy of biliary reconstruction with
or without a removable intraductal stent on reducing biliary complications. Inclusion and randomization are performed
during LT when a duct-to-duct biliary anastomosis smaller than 7 mm in diameter is envisioned. In the intraductal stent
group, a custom-made segment of a T-tube is placed into the bile duct and removed endoscopically 4 to 6 months
later. The surgical technique is described in a video during randomization and is available on the secure website used
for inclusion and randomization. The primary endpoint is the occurrence of biliary complications, including
biliary fistulae and strictures, during the 6 months of follow-up. Secondary evaluation criteria are the incidence of
complications related to the stent placement and its extraction by endoscopy. The inclusion of 248 patients in total has
been determined based on an expected incidence of biliary complications of 25 % in the non-IST group and a 60 %
reduction of biliary complications (10 %) in the IST group.
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Discussion: Biliary complications following LT are significant causes of morbidity, retransplantation, and mortality.
Although controversial, the use of a T-tube has been proven to be useless and even responsible for specific
complications related to the external part of the tube in many studies, including several randomized trials. However,
several studies have identified a small bile duct diameter as a risk factor for biliary stenosis. A threshold of 7 mm was
found to be significantly associated with biliary stenosis. Our team published a preliminary study that included 20
patients using a new technique of intraductal stenting. Only four complications were reported in the overall study
population, whereas no biliary complication occurred in the subgroup of patients who received a whole graft LT.
Moreover, no technical failures and no procedure-related complications were noted before and during the drain
removal. Although an intraductal stent tube in duct-to duct biliary anastomosis seems feasible and safe, a multicenter
randomized controlled trial is needed to validate its benefit as a protective tool against the occurrence of biliary
complications. One original aspect of this protocol is the video demonstration of the surgical procedure, which is
available on the web to standardize and homogenize the technique. The surgical community may be inspired by this
type of tool in the future to minimize technical bias related to technical issues.
Trial registration: NCT02356939, date of registration 2 February 2015.
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Background
Biliary tract reconstruction during liver transplantation
(LT) is the final technical step and the cornerstone of
the procedure and is often performed by a duct-to-duct
anastomosis. Rarely, recipient and donor biliary stump
discrepancies or liver disease-related reasons could lead
to a hepaticojejunostomy. The proper completion of this
technical step is crucial for postoperative outcome [1, 2].
The incidence of biliary complications following liver
transplantation (LT) remains high, ranging from 10 to
50 % of patients among clinical series despite an increas-
ing experience worldwide [2–4]. These complications,
mainly represented by biliary leaks and biliary strictures,
are responsible for substantial post-transplantation mor-
bidity and graft loss. Biliary leakage occurs mostly within
3 months postoperatively. This early complication reaches
a 10 to 20 % incidence rate [3, 4]. Biliary strictures mainly
occur later, within 5 to 8 months and up to 1 year in most.
The reported incidence of biliary strictures still ranges from
5 to 30 % among large and recent clinical series [2, 4].
The use of an external T-tube to reduce biliary com-
plications has been debated for decades [5–10]. The
initial rationale was to facilitate biliary healing and main-
tain easy access to the biliary tract to perform a cholan-
giography until removal of the T-tube in consultation, in
general within 6 weeks post-transplantation [11]. How-
ever, specific complications related to the cholangiog-
raphy, such as cholangitis, and the development of
endoscopic techniques, have reduced its legitimacy.
Moreover, numerous published studies [5–8, 10], includ-
ing three randomized studies [6–8], have shown not only
an absence of difference of biliary complications with or
without the T-tube use but also a specific morbidity re-
lated to the T-tube, such as cholangitis, and biliary leaks
at the time of removal.
Those results have been criticized by two randomized
studies [9, 12]. However, in one of these [9], the biliary
strictures rate was similar between the T-tube and the
non-T-tube group, and a higher general biliary complica-
tion rate (50 %) depended on an increased 14 % rate of
pancreatitis. In the second study, which showed in-
creased biliary strictures in the non-T-tube group in a
monocentric design [12], the general biliary complica-
tions rate was similar, with a diagnosis of biliary stricture
exclusively based on size discrepancy on imaging. The rate
of Kehr-related complications was 23 % (13 % fistulae).
The principal interest of this latter study was the signifi-
cantly increased risk of biliary stricture in patients with
bile duct size < 7 mm.
Based on these results, numerous teams do not use an
external biliary drain in LT anymore. Moreover, the effi-
cacy and safety of endoscopic biliary stenting has been
highlighted in several studies in the treatment of biliary
stenosis [13–17].
In this context, we developed a new technique of intra-
ductal stent tube (IST) placement followed by its endo-
scopic removal in the 4 to 6 months postoperatively. The
rationale was to prevent the biliary complications while
avoiding the side effects related to an external T-tube use.
We published a preliminary study conducted on 20 pa-
tients with a small graft bile duct (<5 mm) [18]. Biliary
complications occurred in four patients, including one
cholangitis, one hemobilia, one asymptomatic leakage,
and one anastomotic stricture. No biliary complication oc-
curred in the subgroup of patients who received a whole
graft LT. No technical failure and no procedure-related
complication were recorded during drain removal. Given
the so–reported feasibility and safety of this innovative
technique, we sought to evaluate its impact on biliary
complications prevention.
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The primary goal of this multicenter, randomized con-
trolled study is to determine the incidence of biliary
complications in the IST group, especially in case of
small bile duct reconstruction, compared to the standard
technique (duct-to-duct biliary reconstruction without
IST) within the first 6 months post-liver transplantation.
The second endpoint is to compare the incidence of
complications related to the stent tube and its extraction
by endoscopy.
Methods
Goals and outcomes
This multicenter randomized controlled study aims at
comparing the efficacy of biliary intraductal stent tube
placement in biliary end-to-end anastomosis to the
standard technique (duct-to-duct biliary reconstruction
without IST) on the incidence of biliary complications,
that is, biliary strictures and biliary stenosis, within the
first 6 months post-liver transplantation.
The primary outcome is the incidence of biliary
strictures and biliary leakage within 6 months post-
transplantation.
A biliary leakage was defined according to the ISGLS
classification [19] as a bilirubin concentration in the
drain fluid at least three times the serum bilirubin con-
centration on or after postoperative day 3 or as the need
for radiologic or operative intervention resulting from
biliary collections or bile peritonitis. A Grade A bile
leakage caused no change in the patients' clinical man-
agement. A Grade B bile leakage required active thera-
peutic intervention but was manageable without
relaparotomy, whereas in Grade C, bile leakage relapar-
otomy was required.
A biliary stenosis was defined by a size discrepancy
between the two sides of the bile duct anastomosis
on specific imaging (MR cholangiography or ERCP),
associated with an upstream bile tract distention, with
a clinical and biological cholestasis (gamma-glutamyl
transferase and alkaline phosphatase three-fold eleva-
tion from baseline associated with an abnormal biliru-
bin serum level within 2 days), after excluding other
cholestasis causes (rejection and viral reactivation).
Secondary endpoints are the incidence of specific
complications related to the IST and its extraction
by endoscopy: cholangitis, stent migration, extraction
difficulties, acute pancreatitis, digestive perforation,
and hemorrhage. The graft and patients’ survival at
6 months will also be analyzed as secondary
endpoints.
Patient selection
Patient inclusion is performed in consultation at the
time of enlistment for LT, where they are informed and
have to sign a written consent.
Inclusion criteria are as follows:
1. Adults older than 18 years-old.
2. Patients eligible for a liver transplantation.
3. Patients’ written informed consent signed.
Exclusion criteria include the following:
1. Biliary reconstruction requires a hepaticojejunostomy
for anatomical/biliary disease reason.
2. Ineligibility for liver transplantation.
Definitive inclusion takes place in the operating room,
during LT, and depends on the fulfillment of the follow-
ing “definitive inclusion criteria”:
1. Duct-to-duct, end-to end biliary reconstruction.
2. Graft or recipient biliary duct diameter ≤ 7 mm.
3. Anatomically entire graft choledoque.
4. No graft from a circulatory arrested donor.
Study course
The study is a multicenter, prospective, randomized con-
trolled study. The follow-up is set at 6 months postoper-
atively to screen the majority of biliary complications.
The inclusion period is set at 2 years, for a total study
duration of 2.5 years.
The patient inclusion will be made in seven liver trans-
plantation centers in France.
Definitive inclusion will take place in the operating
room, during LT, and depends on fulfillment of the
indicated “definitive inclusion criteria” (see above).
The randomization will be performed in the operating
room by the investigator and coordinated by the Clinical
Research Unit of the promoters’ center (Saint Antoine
Hospital, Paris), with specific software accessible on the
Internet.
In the IST group, the surgeon will place the IST in the
bile duct, which is a custom-made segment (2 cm) of an
8 Charrière T-tube. The stent is inserted in the biliary
duct without suture fixation (Fig. 1).
To minimize bias and homogenize the technique, a
short technical explanatory movie was developed by the
principal investigator’s team and provided on the inter-
net. The technique of biliary reconstruction by either
running suture or interrupted stiches is left to the sur-
geon preference because no impact has been demon-
strated on the occurrence of biliary complications.
Each center performs its habitual postoperative follow-
up. Clinical, biological, and radiological data are
collected at Day 1, Day 7, Day 15, Month 1, Month 3,
and Month 6. A Magnetic Resonance Cholangiography
(MRC) is performed at 6 months post-LT, which is after
the stent removal.
Goumard et al. Trials  (2015) 16:598 Page 3 of 6
In the IST group, an endoscopic retrograde cholangio-
pancreatography (ERCP) with sphincterotomy is planned
between the 4th and the 6th month post-transplantation,
requiring a short stay in the hospital, a general anes-
thesia, and clinical and biological tests including plas-
matic lipase dosage at Day 1.
Every undesirable event will be immediately reported
to the sponsor for further investigation of its severity.
Severe undesirable events are previously defined.
Statistical analysis
The inclusion of 248 patients in total has been estimated
based on an expected incidence of biliary complications
of 25 % in the non-IST group, and a 60 % reduction of
biliary complications (10 %) in the IST group with an
alpha risk of 5 % and a beta risk of 20 %.
The statistical analysis will be in an intention-to-treat
fashion. The frequency of occurrence of a biliary
complication will be compared between groups with a χ2
test or a Fisher test as appropriate.
Adjusting factors such as arterial thrombosis or surgi-
cal technique will be managed with logistic regression
models as appropriate.
Ethical approval
This trial has been approved by the Comité de Protection
des Personnes (CPP) Ile de France III - 3170 (File ref:
2014-A00866-41).
Discussion
Despite a global improvement in overall survival rates in
LT in the last decades, decreasing the incidence and
severity of biliary complications remains a major goal
for transplant surgeons.
External drainage using T-tube has not proven its effi-
cacy in a consensual way. Still debated, T-tube place-
ment is not used anymore in numerous teams because
of the nonproven preventative effect on biliary complica-
tions and because of the specific complications related
to its use and removal, such as bile leaks and cholangitis
[5–8, 10]. Moreover, such a hypothetic prevention of
biliary complication is not supported by the fact that
T-tubes are removed early, within the initial 2 months
postoperatively. This delay is probably too short to pre-
vent the development of a biliary stricture. This lack of
long-term effect may be advantageously cleared by the
IST technique. This innovative, easy to reproduce tech-
nique allows a longer stenting effect on biliary reconstruc-
tion and avoids specific morbidity related to the external
biliary drainage [18].
Specific complications related to endoscopic extraction
of the stent and ERCP with sphincterotomy, in general,
may be expected in this study. However, large clinical
studies report very low complication rates; in the study
of Cotton et al. (2009), in an analysis of more than
11,000 procedures, the overall complication rate was
about 4 %, with very low incidence of hemorrhage
(0.3 %) or acute pancreatitis (2 to 3 %) [20]. In our pre-
liminary study carried out on 20 patients, no technical
failures and no procedure-related complications were re-
corded during drain removal. A limited sphincterotomy
was performed in 17 patients of 20 without any com-
plication [18]. The small number of patients and the
single-center referring to an experienced endoscopist
may also explain these results.
Some complications specific to the stent may also be
expected, such as stent migration in the duodenum, in-
fectious cholangitis, or extraction difficulties due to stent
incrustation. In our experience, one cholangitis occurred
and was successfully treated by antibiotics and drain re-
moval. This latter patient had a transpapillary drain that
may explain the occurrence of a backflow into the biliary
Fig. 1 Intraductal stent tube insertion (short movie extracts)
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tract [18]. Consequently, we decided to systematically
place the tube above the ampulla of Vater. One patient
experienced a clinical asymptomatic spontaneous migra-
tion of the stent in the duodenum, without any con-
sequences. No difficulties were recorded during IST
ablation because of stent incrustation, event after more
than a 6-month postoperative delay.
We previously performed this technique in patients
with a graft bile duct diameter less than 5 mm. This
option was based on several studies [12, 21–23] that
demonstrated a significant association between the risk
of biliary stenosis and the small diameter of the biliary
duct. Asian studies [21–23] found a significantly in-
creased risk for less than 5 mm bile duct diameter, but
these studies are conducted on reduced liver grafts ob-
tained from living donors. A recent trial [12] found a
significantly increased risk for bile ducts less than 7 mm
in diameter in 197 transplanted patients from whole
cadaveric liver grafts. Thus, a cut-off value of 7 mm for
graft bile duct diameter was chosen for this trial.
In the design of this trial, we assumed an expected
biliary complication rate in the non-IST group of 25 %.
We considered that these patients with a small bile duct
diameter (<7 mm) presented a higher risk of biliary
strictures, according to the literature. A 60 % reduction
in biliary complications, representing a 10 % biliary com-
plication rate in the IST group, seemed to be a reason-
able goal.
To avoid any bias related to technical issues and
given the multicenter design of the trial, we decided to
produce a movie that clearly explains the procedure
step-by-step. To our knowledge, this is the first time
that such a technical standardization has been used in
the surgical research field, especially its accessibility on
the Internet, which means it always available during the
randomization in the operating theatre. This technique
will be available on a secure website that is already be-
ing used for inclusion and randomization, and later will
be attached to the publication of the results. This
innovative form of surgical diffusion will be useful to
avoid technique bias and to standardize the technique
worldwide when published.
In conclusion, this randomized, multicenter controlled
trial aims at validating this technique as a safe, innova-
tive way to prevent biliary complications in high-risk
patients following liver transplantation.
Trial status
The proposed trial has been validated and accepted for
financial support by the French National Health Ministry
(Programme Hospitalier de Recherche Clinique (PHRC
AOR13028 – P130919)). Patient inclusions have been
ongoing since 30 May 2015.
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